文献速递临床试验与 GCP

疟疾临床试验中的多层级利益相关者参与:应对资源有限环境中临床研究挑战

Multiple-level stakeholder engagement in malaria clinical trials: addressing the challenges of conducting clinical research in resource-limited settings.
PubMed 文献 · Trials · 2018-03-22

本文基于在撒哈拉以南非洲资源有限地区开展的一项孕妇疟疾间歇性预防治疗大型跨国临床试验(NCT01103063),总结了规划与实施中遇到的挑战及多层级利益相关者参与措施。挑战包括全球疟疾协调、国家监管异质性、医疗基础设施不足、当地实践与信念等。国际、国家及社区层面的参与有助于使研究设计符合监管要求并适应当地情况。

要点

  • 资源有限环境中开展跨国临床试验需多层级利益相关者参与。
  • 国际与国家层面参与有助于对齐监管要求并评估基础设施需求。
  • 社区与家庭参与有助于研究设计适应当地实践并准确传达研究信息。

核心结论

  • 国际和国家层面利益相关者参与使申办方能够使研究设计符合卫生和监管机构要求,并在试验启动前了解并解决医疗基础设施需求。
  • 当地利益相关者(包括社区成员、研究参与者和家属)参与使研究者能够使研究设计和实施适应当地考虑,并确保向公众传达准确的研究目的信息。

研究设计与样本

  • 本文为针对在撒哈拉以南非洲资源有限地区开展的一项孕妇疟疾间歇性预防治疗大型跨国临床试验(NCT01103063)的经验总结,描述了规划与实施中遇到的多项挑战及采取的一系列参与措施。

主要发现

  • 遇到的挑战包括与 ongoing 全球疟疾工作的协调、国家监管结构的异质性、次优的医疗基础设施、当地实践与信念,以及对医疗提供者过度信任或怀疑的观点。
  • 参与的国际机构包括世界卫生组织、疟疾妊娠联盟、Steve Biko 生物伦理中心和伦敦卫生与热带医学院。
  • 申办方(Pfizer Inc. 和 Medicines for Malaria Venture)与研究者联系了国家及地区层面利益相关者,如卫生部长和区域/当地社区卫生工作者。
  • 社区参与措施包括与社区领袖召开当地会议解释研究目的并回答社区提出的问题和关切。
  • 研究者还与潜在试验参与者的家庭成员接触,以顾及当地实践与信念。

临床怎么用

  • 在资源有限环境中规划跨国临床试验时,应尽早纳入国际、国家和社区多层级利益相关者参与,以对齐监管要求、评估基础设施需求并适应当地实践与信念。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Multinational clinical trials are logistically complex and require close coordination between various stakeholders. They must comply with global clinical standards and are accountable to multiple regulatory and ethical bodies. In resource-limited settings, it is challenging to understand how to apply global clinical standards to international, national, and local factors in clinical trials, making multiple-level stakeholder engagement an important element in the successful conduct of these clinical trials. MAIN BODY: During the planning and implementation of a large multinational clinical trial for intermittent preventive treatment of malaria in pregnancy in resource-limited areas of sub-Saharan Africa, we encountered numerous challenges, which required implementation of a range of engagement measures to ensure compliance with global clinical and regulatory standards. These challenges included coordination with ongoing global malaria efforts, heterogeneity in national regulatory structures, sub-optimal healthcare infrastructure, local practices and beliefs, and perspectives that view healthcare providers with undue trust or suspicion. In addition to engagement with international bodies, such as the World Health Organization, the Malaria in Pregnancy Consortium, the Steve Biko Centre for Bioethics, and the London School of Hygiene and Tropical Medicine, in order to address the challenges just described, Pfizer Inc. and Medicines for Malaria Venture (the "Sponsoring Entities" for these studies) and investigators liaised with national- and district-level stakeholders such as health ministers and regional/local community health workers. Community engagement measures undertaken by investigators included local meetings with community leaders to explain the research aims and answer questions and concerns voiced by the community. The investigators also engaged with family members of prospective trial participants in order to be sensitive to local practices and beliefs. CONCLUSION: Engagement with key stakeholders at international and national levels enabled the Sponsoring Entities to address challenges by aligning the study design with the requirements of health and regulatory agencies and to understand and address healthcare infrastructure needs prior to trial initiation. Local stakeholder engagement, including community members, study participants, and family enabled the investigators to address challenges by ensuring that study design and conduct were adapted to local considerations and ensuring accurate information about the study aims was shared with the public. TRIAL REGISTRATION: ClinicalTrials.gov, ID: NCT01103063 . Registered on 7 April 2010.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Mtove G, Kimani J, Kisinza W, et al. Multiple-level stakeholder engagement in malaria clinical trials: addressing the challenges of conducting clinical research in resource-limited settings. Trials. 2018. PMID: 29566732. doi:10.1186/s13063-018-2563-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。